Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
Rhythm Pharmaceuticals (RYTM) Prices 4.8M Share Offering at $26/sh
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals (RYTM) Announces Proposed $100M Share Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 42nd Annual Health Care Conference
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 42nd Annual Health Care Conference
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals (RYTM) Prices 5M Share Common Offering at $30/Sh
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals (RYTM) to Offer $150M in Common Stock
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals (RYTM) Prices 8.108M Share Common Offering at $18.50/Sh
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals (RYTM) Announces Proposed $150M Share Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference
-
Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals (RYTM) Prices 5.73M Shares at $26.42
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
-
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
-
Cowen Starts Rhythm Pharmaceuticals (RYTM) at Outperform
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceutical (RYTM) IPO Opens Up 37%
-
Rhythm Pharmaceuticals (RYTM) Prices 7.05M Share IPO at $17/Sh
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering